Table 2.
AAION (n = 12) Mean±SD |
NAION (n = 33) Mean±SD |
CONTROL (n = 35) Mean±SD |
p | |
---|---|---|---|---|
Hb (g/dl) | 12.76 ± 1.02 | 13.15 ± 1.00 | 13.63 ± 1.45 | 0.077a |
PC (103/μL) | 300.75 ± 52.82 | 282.60 ± 36.50 | 270.57 ± 58.05 | 0.182a |
MPV (fL) | 8.50 ± 1.32 | 8.24 ± 0.39 | 7.24 ± 0.31 | <0.001a |
0.305b, <0.001c, <0.001d | ||||
PDW (fL) | 15.16 ± 0.88 | 14.85 ± 0.88 | 14.32 ± 0.72 | 0.003a |
0.297b, 0.002c, 0.009d | ||||
PCT (%) | 0.21 ± 0.03 | 0.20 ± 0.03 | 0.18 ± 0.03 | 0.015a |
0.411b, 0.011c, 0.015d | ||||
NLR | 2.72 ± 0.84 | 2.04 ± 0.42 | 1.97 ± 0.31 | <0.001a |
0.001b, <0.001c, 0.417d |
Data are presented as mean±standard deviation. AAION: arteritic anterior ischemic optic neuropathy; NAION: non-arteritic anterior ischemic optic neuropathy; Hb: haemoglobin; PC: platelet count; MPV: mean platelet volume; PDW, platelet distribution width; PCT: plateletcrit; NLR: the neutrophil to lymphocyte ratio, fL: femtoliter.
aSignificance in analysis of variance (comparison among three groups)
bSignificance between AAION and NAION group (pairwise comparison)
cSignificance between AAION and control group (pairwise comparison)
dSignificance between NAION and control group (pairwise comparison)